Nymox Pharmaceutical Corp NYMXF
Trading Information
- Previous Close Price
- $0.03
- Day Range
- $0.03–0.03
- 52-Week Range
- $0.00–0.20
- Bid/Ask
- $0.02 / $0.10
- Shares Outstanding
- 105.04M
- Market Cap
- $3.03M
- Volume/Avg
- 21,624 / 15,826
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing and commercializing NYMOZARFEX (fexapotide/NX-1207) for the treatment of benign prostatic hyperplasia (BPH) and low-grade localized prostate cancer. The company also has an extensive patent portfolio covering its investigational drug and other therapeutic and diagnostic indications, including patent rights related to the use of statin drugs for the treatment and prevention of Alzheimer's disease. The company operates in one reportable segment focused on the research and development of products for the aging population.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 0
- Website
- https://www.nymox.com
Valuation
|
Metric
|
NYMXF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
NYMXF
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.06 |
Interest Coverage | −6.29 |
Quick Ratio
NYMXF
Profitability
|
Metric
|
NYMXF
|
|---|---|
Return on Assets (Normalized) | −417.40% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
NYMXF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|Tx&ytl | LOCK|%CP?K | $129B | |||
| Moderna Inc
MRNA
| LOCK|JnKyHM | LOCK|G#< | $90B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|%tV%%c | LOCK|$@#m% | $77B | |||
| argenx SE ADR
ARGX
| LOCK|x>Qjpt< | LOCK|@$ | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|T&HQ<g< | LOCK|%t | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|G<t!%s | LOCK|F?>%> | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|HRlNc<s | LOCK|?%^&# | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|T>><F@t | LOCK|@D | $24B | |||
| Incyte Corp
INCY
| LOCK|@<YWZRY | LOCK|#Px | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|$p>lhQ# | LOCK|#J | $14B |
United States